<DOC>
	<DOCNO>NCT02122406</DOCNO>
	<brief_summary>The primary endpoint study evaluate prevalence anxiety depressive disorder , relationship disease activity , patient rheumatoid arthritis treat biological drug</brief_summary>
	<brief_title>Depression Anxiety Rheumatoid Arthritis</brief_title>
	<detailed_description>The prevalence anxiety depressive disorder assesed HADS questionnaire time visit</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<criteria>age &gt; 18 year diagnosis rheumatoid arthritis accord 2010 Classification American College Rheumatology/ European League Against Rheumatism ( ACR/EULAR ) Criteria able compile questionnaire current treatment biological diseasemodifying antirheumatic drug Current treatment anxiety depressive disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Depression</keyword>
	<keyword>Anxiety</keyword>
	<keyword>DAS28</keyword>
	<keyword>HADS</keyword>
</DOC>